References
- Abe, M., J. Hamada, O. Takahashi, Y. Takahashi, M. Tada, M. Miyamoto, T. Morikawa, S. Kondo, and T. Moriuchi. 2006. Disordered expression of HOX genes in human non-small cell lung cancer. Oncol. Rep. 15 (4):797–802. doi:https://doi.org/10.3892/or.15.4.797.
- Abnet, C. C., N. D. Freedman, N. Hu, Z. Wang, K. Yu, X. O. Shu, J. M. Yuan, W. Zheng, S. M. Dawsey, L. M. Dong, et al. 2010. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 42(9):764–67. doi:https://doi.org/10.1038/ng.649.
- Baylin, S. B., and J. E. Ohm. 2006. Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction?. Nat. Rev. Cancer 6 (2):107–16. doi:https://doi.org/10.1038/nrc1799.
- Bedard, L. L., G. B. J. Smith, K. R. Reid, D. Petsikas, and T. E. Massey. 2002. Investigation of the role of lipoxygenase in bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung. Chem. Res. Toxicol. 15 (10):1267–73. doi:https://doi.org/10.1021/tx025524m.
- Belinsky, S. A. 2005. Silencing of genes by promoter hypermethylation: Key event in rodent and human lung cancer. Carcinogenesis 26 (9):1481–87. doi:https://doi.org/10.1093/carcin/bgi020.
- Borriello, A., I. Caldarelli, D. Bencivenga, M. Criscuolo, V. Cucciolla, A. Tramontano, A. Oliva, S. Perrotta, and F. D. Ragione. 2011. p57Kip2and cancer: Time for a critical appraisal. Mol. Cancer Res. 9 (10):1269–84. doi:https://doi.org/10.1158/1541-7786.MCR-11-0220.
- Breitling, L. P. 2013. Current genetics and epigenetics of smoking/tobacco-related cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 33 (7):1468–72. doi:https://doi.org/10.1161/ATVBAHA.112.300157.
- Brunnemann, K. D., B. Prokopczyk, M. V. Djordjevic, and D. Hoffmann. 1996. Formation and analysis of tobacco-specific N-nitrosamines. Crit. Rev. Toxicol. 26 (2):121–37. doi:https://doi.org/10.3109/10408449609017926.
- Brzeziańska, E., A. Dutkowska, and A. Antczak. 2013. The significance of epigenetic alterations in lung carcinogenesis. Mol. Biol. Rep. 40 (1):309–25. doi:https://doi.org/10.1007/s11033-012-2063-4.
- Burgess, A., K. M. Chia, S. Haupt, D. Thomas, Y. Haupt, and E. Lim. 2016. Clinical overview of MDM2/X-targeted therapies. Front. Oncol. 6:7. doi:https://doi.org/10.3389/fonc.2016.00007.
- Cao, J., G. Xu, J. Lan, Q. Huang, Z. Tang, and L. Tian. 2016. High expression of piwi-like RNA mediated gene silencing 1 is associated with poor prognosis via regulating transforming growth factor-β receptors and cyclin-dependent kinases in breast cancer. Mol. Med. Rep. 13 (3):2829–35. doi:https://doi.org/10.3892/mmr.2016.4842.
- Chen, Y., D. Wang, H. Peng, X. Chen, X. Han, J. Yu, W. Wang, L. Liang, Z. Liu, Y. Zheng, et al. 2019. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression. Mol. Cancer 18(1):1. doi:https://doi.org/10.1186/s12943-018-0930-x.
- Chen, Y., H. Xin, H. Peng, Q. Shi, M. Li, J. Yu, Y. Tian, X. Han, X. Chen, Y. Zheng, et al. 2020. Hypomethylation-linked activation of PLCE1 impedes autophagy and promotes tumorigenesis through MDM2-mediated ubiquitination and destabilization of p53. Cancer Res. 80 (11):2175–89. doi: https://doi.org/10.1158/0008-5472.CAN-19-1912.
- Cochard, M., F. Ledoux, and Y. Landkocz. 2020. Atmospheric fine particulate matter and epithelial mesenchymal transition in pulmonary cells: State of the art and critical review of the in vitro studies. J. Toxicol. Environ. Health B 23 (7):293–318. doi:https://doi.org/10.1080/10937404.2020.1816238.
- Cohen, S. M., Y. Zhongyu, and J. S. Bus. 2020. Relevance of mouse lung tumors to human risk assessment. J. Toxicol. Environ. Health B 23 (5):214–41. doi:https://doi.org/10.1080/10937404.2020.1763879.
- Du, Z., X. Zhou, Y. Ling, Z. Zhang, and Z. Su. 2010. agriGO: A GO analysis toolkit for the agricultural community. Nucl. Acids Res. 38 (suppl_2):W64–W70. doi:https://doi.org/10.1093/nar/gkq310.
- Eeckhoute, J., P. Formstecher, and B. Laine. 2004. Hepatocyte nuclear factor 4α enhances the hepatocyte nuclear factor 1α-mediated activation of transcription. Nucl. Acids Res. 32 (8):2586–93. doi:https://doi.org/10.1093/nar/gkh581.
- Ehrlich, M. 2009. DNA hypomethylation in cancer cells. Epigenomics 1 (2):239–59. doi:https://doi.org/10.2217/epi.09.33.
- Embade, N., D. Fernández-Ramos, M. Varela-Rey, N. Beraza, M. Sini, V. Gutiérrez de Juan, A. WoodhooN. Martínez-López, B. Rodríguez-Iruretagoyena, F. J. Bustamante, et al. 2012. Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation. Hepatology 55(4):1237–48. doi:https://doi.org/10.1002/hep.24795.
- Ferlay, J., M. Ervik, F. Lam, M. Colombet, L. Mery, M. Piñeros, A. Znaor, I. Soerjomataram, and F. Bray. 2018. Global cancer observatory: Cancer today. Lyon, France: International agency for research on cancer. [Cited 5 November 2018]. Available from: https://gco.iarc.fr/today.
- Ford, H. L. 1998. Homeobox genes: A link between development, cell cycle, and cancer. Cell Biol. Int. 22 (6):397–400. doi:https://doi.org/10.1006/cbir.1998.0329.
- Ge, G.-Z., T.-R. Xu, and C. Chen. 2015. Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms. Acta Biochim. Biophys. Sin. (Shanghai) 47 (7):477–87. doi:https://doi.org/10.1093/abbs/gmv041.
- Han, Y.-N., Y. Li, S.-Q. Xia, Y.-Y. Zhang, J.-H. Zheng, and W. Li. 2017. PIWI proteins and PIWI-interacting RNA: Emerging roles in cancer. Cell. Physiol. Biochem. 44 (1):1–20. doi:https://doi.org/10.1159/000484541.
- Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387 (6630):296–99. doi:https://doi.org/10.1038/387296a0.
- He, W., Z. Wang, Q. Wang, Q. Fan, C. Shou, J. Wang, K.-E. Giercksky, J. M. Nesland, and Z. Suo. 2009. Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. BMC Cancer 9 (1):426. doi:https://doi.org/10.1186/1471-2407-9-426.
- Hecht, S. S. 2012. Lung carcinogenesis by tobacco smoke. Int. J. Cancer 131 (12):2724–32. doi:https://doi.org/10.1002/ijc.27816.
- Hisamoto, A., E. Kondo, K. Kiura, T. Okada, S. Hosokawa, J. Mimoto, N. Takigawa, M. Tabata, and M. Tanimoto. 2007. Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice. Lung Cancer 58 (1):15–20. doi: https://doi.org/10.1016/j.lungcan.2007.05.012.
- Hoffmann, D., K. D. Brunnemann, B. Prokopczyk, and M. V. Djordjevic. 1994. Tobacco-specific N-nitrosamines and ARECA- derived N-nitrosamines: Chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health A 41 (1):1–52. doi:https://doi.org/10.1080/15287399409531825.
- Hoffmann, D., A. Castonguay, A. Rivenson, and S. S. Hecht. 1981. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine in Syrian golden hamsters. Cancer Res. 41 (6):2386–93.
- Hoffmann, D., A. Rivenson, and S. S. Hecht. 1996. The biological significance of tobacco-specific N-nitrosamines: Smoking and adenocarcinoma of the lung. Crit. Rev. Toxicol. 26 (2):199–211. doi:https://doi.org/10.3109/10408449609017931.
- Hu, Y., and N. F. Mivechi. 2006. Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26. Mol. Cell. Biol. 26 (8):3282–94. doi:https://doi.org/10.1128/MCB.26.8.3282-3294.2006.
- Hwang-Verslues, W. W., and F. M. Sladek. 2010. HNF4α – Role in drug metabolism and potential drug target?. Curr. Opin. Pharmacol 10 (6):698–705. doi:https://doi.org/10.1016/j.coph.2010.08.010.
- Imanishi, M., Y. Yamamoto, X. Wang, A. Sugaya, M. Hirose, S. Endo, Y. Natori, K. Yamato, and I. Hyodo. 2019. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells. Cancer Sci. 110 (2):639–49. doi:https://doi.org/10.1111/cas.13893.
- International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. vol. 83. Lyon, FR: IARC; 2004. Tobacco Smoke and Involuntary Smoking. pp. 33–1187.
- Jalas, J. R., X. Ding, and S. E. Murphy. 2003. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Drug Metab. Dispos. 31 (10):1199–202. doi:https://doi.org/10.1124/dmd.31.10.1199.
- Jia, B.-Y., R.-H. Yang, W.-J. Jiao, and K.-H. Tian. 2019. Investigation of the effect of P14 promoter aberrant methylation on the biological function of human lung cancer cells. Thorac. Cancer 10 (6):1388–94. doi:https://doi.org/10.1111/1759-7714.13082.
- Jin, X., B. Eroglu, W. Cho, Y. Yamaguchi, D. Moskophidis, and N. F. Mivechi. 2012. Inactivation of heat shock factor Hsf4 induces cellular senescence and suppresses tumorigenesis in vivo in vivo. Mol. Cancer Res 10 (4):523–34. doi:https://doi.org/10.1158/1541-7786.MCR-11-0530.
- Jung, M., S. Kadam, W. Xiong, T. A. Rauch, S.-G. Jin, and G. P. Pfeifer. 2015. MIRA-seq for DNA methylation analysis of CpG islands. Epigenomics 7 (5):695–706. doi:https://doi.org/10.2217/epi.15.33.
- Kim, D.-S., M.-J. Kim, J.-Y. Lee, S.-M. Lee, J.-Y. Choi, G.-S. Yoon, Y.-K. Na, H.-S. Hong, S.-G. Kim, J.-E. Choi, et al. 2009. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features. Mol. Carcinogen. 48(12):1109–15. doi:https://doi.org/10.1002/mc.20561.
- Liu, J. J., R. Shen, L. Chen, Y. Ye, G. He, K. Hua, D. Jarjoura, T. Nakano, G. K. Ramesh, C. L. Shapiro, et al. 2010. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int. J. Clin. Exp. Pathol. 3 (4):328–37.
- Lodovici, M., V. Akpan, S. Caldini, B. Akanju, and P. Dolara. 2007. DNA solution(R) in cigarette filters reduces polycyclic aromatic hydrocarbon (PAH) levels in mainstream tobacco smoke. Food Chem. Toxicol. 45 (9):1752–56. doi:https://doi.org/10.1016/j.fct.2007.03.007.
- Lu, Y., Y.-T. Chan, H.-Y. Tan, S. Li, N. Wang, and Y. Feng. 2020. Epigenetic regulation in human cancer: The potential role of epi-drug in cancer therapy. Mol. Cancer 19 (1):79. doi:https://doi.org/10.1186/s12943-020-01197-3.
- Malhotra, J., M. Malvezzi, E. Negri, C. L. Vecchia, and P. Boffetta. 2016. Risk factors for lung cancer worldwide. Eur. Respir. J. 48 (3):889–902. doi:https://doi.org/10.1183/13993003.00359-2016.
- Mark, M., F. M. Rijli, and P. Chambon. 1997. Homeobox genes in embryogenesis and pathogenesis. Pediatr. Res. 42 (4):421–29. doi:https://doi.org/10.1203/00006450-199710000-00001.
- Marsit, C. J. 2015. Influence of environmental exposure on human epigenetic regulation. J. Exp. Biol. 218 (1):71–79. doi:https://doi.org/10.1242/jeb.106971.
- Martin, B. L., L. C. Thompson, Y. H. Kim, C. King, S. Snow, M. Schladweiler, N. Haykal-Coates, I. George, M. I. Gilmour, U. P. Kodavanti, et al. 2020. Peat smoke inhalation alters blood pressure, baroreflex sensitivity, and cardiac arrhythmia risk in rats. J. Toxicol. Environ. Health A 83 (23–24):748–63. doi:https://doi.org/10.1080/15287394.2020.1826375.
- McCartney, D. L., A. J. Stevenson, R. F. Hillary, R. M. Walker, M. L. Bermingham, S. W. Morris, T.-K. Clarke, A. Campbell, A. D. Murray, H. C. Whalley, et al. 2018. Epigenetic signatures of starting and stopping smoking. E BioMedicine 37:214–20. doi: https://doi.org/10.1016/j.ebiom.2018.10.051.
- McCurdy, R. D., J. J. McGrath, and A. Mackay-Sim. 2008. Validation of the comparative quantification method of real-time PCR analysis and a cautionary tale of housekeeping gene selection. Gene Ther. Mol. Biol. 12:15–24.
- Mehrotra, J., M. Vali, M. McVeigh, S. L. Kominsky, M. J. Fackler, J. Lahti-Domenici, K. Polyak, N. Sacchi, E. Garrett-Mayer, P. Argani, et al. 2004. Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin. Cancer Res. 10(9):3104–09. doi:https://doi.org/10.1158/1078-0432.CCR-03-0118.
- Morgan, J. C., M. J. Byron, S. A. Baig, I. Stepanov, and N. T. Brewer. 2017. How people think about the chemicals in cigarette smoke: A systematic review. J. Behav. Med 40 (4):553–64. doi:https://doi.org/10.1007/s10865-017-9823-5.
- Nakai, A., M. Tanabe, Y. Kawazoe, J. Inazawa, R. I. Morimoto, and K. Nagata. 1997. HSF4, a new member of the human heat shock factor family which lacks properties of a transcriptional activator. Mol. Cell Biol 17 (1):469–81. doi:https://doi.org/10.1128/MCB.17.1.469.
- Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358 (6381):80–83. doi:https://doi.org/10.1038/358080a0.
- Oliner, J. D., A. Y. Saiki, and S. Caenepeel. 2016. The role of MDM2 amplification and overexpression in tumorigenesis. Cold Spring Harb. Perspect. Med. 6 (6):a026336. doi:https://doi.org/10.1101/cshperspect.a026336.
- Oshima, T., T. Kawasaki, R. Ohashi, G. Hasegawa, S. Jiang, H. Umezu, Y. Aoyagi, H. Iwanari, T. Tanaka, T. Hamakubo, et al. 2007. Downregulated p1 promoter-driven hepatocyte nuclear factor-4α expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. Pathol. Int. 57(2):82–90. doi:https://doi.org/10.1111/j.1440-1827.2006.02061.x.
- Pellegrino, M., F. Mancini, R. Lucà, A. Coletti, N. Giacchè, I. Manni, I. Arisi, F. Florenzano, E. Teveroni, M. Buttarelli, et al. 2015. Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy. Cancer Res. 75(21):4560–72. doi:https://doi.org/10.1158/0008-5472.CAN-15-0439.
- Puustinen, M. C., and L. Sistonen. 2020. Molecular mechanisms of heat shock factors in cancer. Cells 9 (5):1202. doi:https://doi.org/10.3390/cells9051202.
- Qiao, D., A.-M. Zeeman, W. Deng, L. H. J. Looijenga, and H. Lin. 2002. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated with seminomas. Oncogene 21 (25):3988–99. doi:https://doi.org/10.1038/sj.onc.1205505.
- Qiu, Z., Y. Li, B. Zeng, X. Guan, and H. Li. 2018. Downregulated CDKN1C/p57kip2 drives tumorigenesis and associates with poor overall survival in breast cancer. Biochem. Biophys. Res. Commun. 497 (1):187–93. doi:https://doi.org/10.1016/j.bbrc.2018.02.052.
- Raman, V., S. A. Martensen, D. Reisman, E. Evron, W. F. Odenwald, E. Jaffee, J. Marks, and S. Sukumar. 2000. Compromised HOXA5 function can limit p53 expression in human breast tumors. Nature 405 (6789):974–78. doi:https://doi.org/10.1038/35016125.
- Raveh, T., G. Droguett, M. S. Horwitz, R. A. DePinho, and A. Kimchi. 2001. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat. Cell Biol. 3(1):1–7. doi:https://doi.org/10.1038/35050500.
- Rioux, N., and A. Castonguay. 1998. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-3981. Cancer Res. 58 (23):5354–60
- Schaal, C., and S. P. Chellappan. 2014. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol. Cancer Res. 12 (1):14–23. doi:https://doi.org/10.1158/1541-7786.MCR-13-0541.
- Schlicht, K. E., J. Z. Berg, and S. E. Murphy. 2009. Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines. Drug Metab. Dispos. 37 (3):665–71. doi:https://doi.org/10.1124/dmd.108.025072.
- Seiler, C. L., J. M. Song, J. Fernandez, J. E. Abrahante, T. J. Y. Kono, Y. Chen, Y. Ren, F. Kassie, and N. Y. Tretyakova. 2019. Epigenetic changes in alveolar type II lung cells of A/J mice following intranasal treatment with lipopolysaccharide. Chem. Res. Toxicol. 32 (5):831–39. doi: https://doi.org/10.1021/acs.chemrestox.9b00015.
- Seiler, C. L., J. M. Song, D. Kotandeniya, J. Chen, T. J. Y. Kono, Q. Han, M. Colwell, B. Auch, A. L. Sarver, P. Upadhyaya, et al. 2020. Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lung. Sci. Rep. 2020(1):11290. doi:https://doi.org/10.1038/s41598-020-67502-8.
- Sel, S., T. Ebert, G. U. Ryffel, and T. Drewes. 1996. Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4α and HNF1α. Cancer Lett. 101 (2):205–10. doi:https://doi.org/10.1016/0304-3835(96)04136-5.
- Sharma, A. K., M. C. Nelson, J. E. Brandt, M. Wessman, N. Mahmud, K. P. Weller, and R. Hoffman. 2001. Human CD34(+) stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood 97 (2):426–34. doi:https://doi.org/10.1182/blood.V97.2.426.
- Shimada, T. 2006. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metabolism and Pharmacokinetics 21 (4):257–76. doi:https://doi.org/10.2133/dmpk.21.257.
- Shin, J. Y., H. S. Kim, K. S. Lee, J. Kim, J. B. Park, M. H. Won, S. W. Chae, Y. H. Choi, K. C. Choi, Y. E. Park, et al. 2000. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer. Exp. Mol. Med. 32(2):79–83. doi:https://doi.org/10.1038/emm.2000.14.
- Shiraishi, M., A. Sekiguchi, M. J. Terry, A. J. Oates, Y. Miyamoto, Y. H. Chuu, M. Munakata, and T. Sekiya. 2002. A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for identification of tumor suppressor genes. Oncogene 21 (23):3804–13. doi:https://doi.org/10.1038/sj.onc.1205454.
- Silberg, D. G., G. P. Swain, E. R. Suh, and P. G. Traber. 2000. Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 119 (4):961–71. doi:https://doi.org/10.1053/gast.2000.18142.
- Suh, E. R., C. S. Ha, E. B. Rankin, M. Toyota, and P. G. Traber. 2002. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. J. Biol. Chem. 277 (39):35795–800. doi:https://doi.org/10.1074/jbc.M205567200.
- Sun, Y., S.-D. Jin, Q. Zhu, L. Han, J. Feng, X.-Y. Lu, W. Wang, F. Wang, and R.-H. Guo. 2017. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression. Oncotarget 8 (17):28297–311. doi:https://doi.org/10.18632/oncotarget.16044.
- Sung, H., J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3):209–49. doi:https://doi.org/10.3322/caac.21660.
- Tan, Y., L. Liu, M. Liao, C. Zhang, S. Hu, M. Zou, M. Gu, and X. Li. 2015. Emerging roles for PIWI proteins in cancer. Acta Biochim. Biophys. Sin. (Shanghai) 47 (5):315–24. doi: https://doi.org/10.1093/abbs/gmv018.
- Tanaka, T., S. Jiang, H. Hotta, K. Takano, H. Iwanari, K. Sumi, K. Daigo, R. Ohashi, M. Sugai, C. Ikegame, et al. 2006. Dysregulated expression of p1 and p2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J. Pathol. 208(5):662–72. doi:https://doi.org/10.1002/path.1928.
- Tang, Y., G. Xiao, Y. Chen, and Y. Deng. 2018. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Anticancer Drugs 29 (8):725–35. doi:https://doi.org/10.1097/CAD.0000000000000650.
- Tian, H. S., M. Q. Liu, W. Q. Gao, R. D. Zuo, Y. Y. Xiong, and Z. F. Chen. 1984. Induction of lung carcinoma by intralobar bronchial instillation of iodized oil in rats. Chin. Med. J. 97 (1):36–40.
- Vuillemenot, B. R., L. C. Pulling, W. A. Palmisano, J. A. Hutt, and S. A. Belinsky. 2004. Carcinogen exposure differentially modulates RAR-β promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Carcinogenesis 25 (4):623–29. doi:https://doi.org/10.1093/carcin/bgh038.
- Wang, -C.-C., K.-Y. Su, H.-Y. Chen, S.-Y. Chang, C.-F. Shen, C.-H. Hsieh, Q.-S. Hong, -C.-C. Chiang, G.-C. Chang, S.-L. Yu, et al. 2015. HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma. PLoS One. 10(4):e0124191. doi:https://doi.org/10.1371/journal.pone.0124191.
- Wang, D.-W., Z.-H. Wang, -L.-L. Wang, Y. Song, and G.-Z. Zhang. 2014. Overexpression of hiwi promotes growth of human breast cancer cells. Asian Pac. J. Cancer Prev. 15 (18):7553–58. doi:https://doi.org/10.7314/APJCP.2014.15.18.7553.
- Wang, J., X.-F. Yu, N. OUYang, Q.-L. Luo, S.-Y. Zhao, X.-F. Guan, T. Chen, and J.-X. Li. 2019. Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma. J. Toxicol. Environ. Health A 82 (1):37–45. doi: https://doi.org/10.1080/15287394.2018.1551645.
- Wang, L. D., F. Y. Zhou, X. M. Li, L. D. Sun, X. Song, Y. Jin, J. M. Li, G. O. Kong, H. Qi, J. Cui, et al. 2010. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet. 42(9):759–63. doi:https://doi.org/10.1038/ng.648.
- Wang, Y., Y. Liu, X. Shen, X. Zhang, X. Chen, C. Yang, and H. Gao. 2012. The PIWI protein acts as a predictive marker for human gastric cancer. Int. J. Clin. Exp. Pathol. 5 (4):315–25.
- Weber, J. D., L. J. Taylor, M. F. Roussel, C. J. Sherr, and D. Bar-Sagi. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1 (1):20–26. doi:https://doi.org/10.1038/8991.
- Yamazaki, H., Y. Inui, C. H. Yun, F. P. Guengerich, and T. Shimada. 1992. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13 (10):1789–94. doi:https://doi.org/10.1093/carcin/13.10.1789.
- Yu, X.-F., J. Wang, N. OUYang, S. Guo, H. Sun, J. Tong, T. Chen, and J. Li. 2019. The role of miR-130a-3p and SPOCK1 in tobacco exposed bronchial epithelial BEAS-2B transformed cells: Comparison to A549 and H1299 lung cancer cell lines. J. Toxicol. Environ. Health A 82 (15):862–69. doi:https://doi.org/10.1080/15287394.2019.1664479.
- Yusuf, D., S. L. Butland, M. I. Swanson, E. Bolotin, A. Ticoll, W. A. Cheung, X. Y. C. Zhang, C. T. D. Dickman, D. L. Fulton, J. S. Lim, et al. 2012. The transcription factor encyclopedia. Genome Biol. 13(3):R24. doi:https://doi.org/10.1186/gb-2012-13-3-r24.